Medicine

Kidney disease affects millions of Americans, but corporate capture of dialysis, along with disparities in treatment and transplant access, mean that not everyone's journey is the same

A new California law aims to curb what sponsors say is profiteering by dialysis centers. But are there any easy answers?

Even with vaccines on the way, treatments are needed to prevent the disease from getting worse—and to be ready for COVID-25, COVID-37, and so on

The FDA issued the emergency use authorization for the vaccine late on Friday. And immunizations of health care workers and long-term care facility residents could begin within days​

Stephen Hahn describes how the agency will evaluate vaccines for emergency authorization

Anyone who’s been hospitalized has probably asked this question—and probably never found out

In the U.S., health workers come first. But for other groups, scientists and policy makers are weighing a mix of disease risks, logistics and ethics

Mathematicians model pandemic scenarios by plugging thorny ethical and logistical issues into calculations

Paratek Pharmaceuticals made a life-saving drug and got it approved. So why is the company’s long-term survival still in question?

A vaccine logistics expert explains how millions of frozen vials will be widely distributed

They could ultimately be used to find diseases the way blood tests do now—but cheaper and more easily

Much of the pioneering work on mRNA vaccines was done with government money, though drugmakers could walk away with big profits